Metarmor
2015
FOUNDED
PRIVATE
STATUS
Angel
LATEST DEAL TYPE
$359K
LATEST DEAL AMOUNT
Description
Developer of drug for prevention of hearing loss. The company specializes in developing and commercializing a drug that protects hair cells in the inner ear for prevention of hearing loss and auditory damage.
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 307 North Polktown Road
- Glen Gardner, NJ 08826
- United States
+1 (908) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Metarmor’s full profile, request a free trial.
Metarmor Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 09-Jun-2017 | $359K | 00000 | Completed | Startup |
Metarmor Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Jennifer Seibert | Chief Executive Officer & Board Member |